Effect of early treatment with ivermectin and doramectin on the dynamics of antibody response in cattle naturally infested by Hypoderma lineatum and H. bovis.
The field efficacy of two avermectins (ivermectin and doramectin) and the subsequent development of the antibody response were assessed in cows naturally infested with first-instar larvae (L-1) of Hypoderma sp. Twenty-eight Frisian cows were randomly divided into three groups while the first-instar larvae were still in migration: Group 1 (G-C) untreated control; Group 2 (G-Iv), treated with ivermectin injectable (0.2 mg kg-1 body weight) and Group 3 (G-Dor), which received doramectin injectable (0.2 mg kg-1 body weight). Serum antibody response was studied by an indirect ELISA test using, as antigen, the hypodermin C obtained from L-1 of H. lineatum. In treated animals no grubs were present on the back at any time during the trial, whereas a variable number of nodules were found in untreated animals. Both avermectins showed total efficacy against L-1 of Hypoderma sp., and there were no local or general reactions. In ivermectin-treated cattle serum antibody levels declined from one month p.t., while in those treated with doramectin they started to fall two weeks later, but no differences were found among both groups. On the other hand, G-C antibody levels progressively increased and remained high until December, when the first grubs became detectable on the back; after that, they began to decline. Early treatments against Hypoderma sp. have an influence on the results of ELISA, so they must be considered to determine the most suitable time for blood sampling.
Panadero
R
R
Facultad de Veterinaria, Universidad de Santiago de Compostela, Spain.
López
C
C
Mezo
M
M
Morrondo
P
P
Díez-Baños
P
P
D000818:Animals; D000906:Antibodies / Q000097:blood*; D002417:Cattle; D002418:Cattle Diseases; D004175:Diptera; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D007000:Hypodermyiasis / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary*; D007306:Insecticides / Q000627:therapeutic use*; D007559:Ivermectin / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D007814:Larva
D000906:Antibodies; D007306:Insecticides; D007559:Ivermectin; C084101:doramectin